© 2004 European Society of Cardiology
The effect of dietary sodium restriction on neurohumoral activity and renal dopaminergic response in patients with heart failure
a Unit of Cardiovascular Research and Development Piso 9, Porto, Portugal
b Department of Medicine – Medicine B, Hospital S. João Porto, Portugal
c Institute of Pharmacology and Therapeutics, University of Porto Medical School Porto, Portugal
d Department of Medicine, Division of Nephrology, Hospital S. João Porto, Portugal
* Corresponding author. Present address: Margarida Isabel Ribeiro de Cavadas Pereira e Alvelos, Unidade de Investigação e Desenvolvimento Cardiovascular do Porto, Piso 9, Hospital de S. João, Alameda Hernâni Monteiro, 4200 Porto, Portugal. Tel.: +351-225096369; Fax: +351-225089788. E-mail address: malvelos{at}netcabo.pt
| Abstract |
|---|
Background: This work evaluates the effect of a low-sodium diet on clinical and neurohumoral parameters and on renal dopaminergic system activity in heart failure (HF) patients.
Methods: We included 24 patients with mild-to-moderate stable HF with left ventricle ejection fraction <40%. Twelve patients were studied before and after a 15-day low-sodium diet; 12 maintained their usual diet. Serum sodium and creatinine, plasma L-DOPA, dopamine, its metabolites, BNP and aldosterone, and 24-h urinary sodium, creatinine, L-DOPA, dopamine and metabolites were measured.
Results: The two groups were matched respecting to demographic and clinical parameters. Low-sodium diet caused significant reductions in weight, 24-h urinary volume and sodium and sodium fractional excretion. Renal delivery of L-DOPA and urinary excretion of L-DOPA significantly decreased while dopamine and metabolites were not affected. Urinary dopamine/L-DOPA and urinary dopamine/renal delivery of L-DOPA ratios increased, plasma L-DOPA decreased and plasma dopamine increased. Plasma aldosterone slightly rose, BNP decreased and noradrenaline and adrenaline increased. NYHA functional class was not affected by sodium restriction. Controls showed no differences.
Conclusions: These results suggest that sodium restriction leads to activation of antinatriuretic antidiuretic systems in HF patients. However, renal ability to synthesize dopamine is increased in this condition, probably as a counter-regulatory mechanism.
Key Words: Abbreviations BNP, B-type natriuretic peptide DOPAC, 3,4-dihydroxyphenylacetic acid HF, heart failure L-DOPA, L-3,4-dihydroxyphenylalanine
Received September 1, 2003; Revised November 11, 2003; Accepted November 19, 2003
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
B. Riegel, D. K. Moser, S. D. Anker, L. J. Appel, S. B. Dunbar, K. L. Grady, M. Z. Gurvitz, E. P. Havranek, C. S. Lee, J. Lindenfeld, et al. State of the Science: Promoting Self-Care in Persons With Heart Failure: A Scientific Statement From the American Heart Association Circulation, September 22, 2009; 120(12): 1141 - 1163. [Full Text] [PDF] |
||||
![]() |
K. R. Beich and C. Yancy The Heart Failure and Sodium Restriction Controversy: Challenging Conventional Practice Nutr Clin Pract, October 1, 2008; 23(5): 477 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Moinier and T. B. Drueke Aphrodite, sex and salt--from butterfly to man Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2154 - 2161. [Full Text] [PDF] |
||||
![]() |
M. Damgaard, J. P. Goetze, P. Norsk, and N. Gadsboll Altered sodium intake affects plasma concentrations of BNP but not proBNP in healthy individuals and patients with compensated heart failure Eur. Heart J., November 2, 2007; 28(22): 2726 - 2731. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Garland, S. R. Raj, B. K. Black, P. A. Harris, and D. Robertson The hemodynamic and neurohumoral phenotype of postural tachycardia syndrome Neurology, August 21, 2007; 69(8): 790 - 798. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Damgaard, P. Norsk, F. Gustafsson, J. K. Kanters, N. J. Christensen, P. Bie, L. Friberg, and N. Gadsboll Hemodynamic and neuroendocrine responses to changes in sodium intake in compensated heart failure Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2006; 290(5): R1294 - R1301. [Abstract] [Full Text] [PDF] |
||||





